Abstract
Intravenous Bortezomib (IV) infusion after Non Response to Subcutaneous Bortezomib (SQ) administration can induce transitory responses in multiple myeloma patients: is some patient more sensitive to the IV bortezomib?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
